NOT
FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY)
IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO
SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS
OF THAT JURISDICTION.
Bridgepoint Group
plc
("Bridgepoint" or the
"Company")
Pricing of US Private
Placement of Notes
Bridgepoint today announces that the
Bridgepoint group (the "Group") has successfully priced US$430
million of US Private Placement ("USPP") notes. The USPP will be
structured in 4 tranches, with maturities of 3, 5, 7 and 10 years
and an average coupon of 6.17 per cent.
Proceeds from the USPP will provide
the Group with additional resources to continue its strategic
growth plans, and in part will be used to refinance certain ECP
debt following the ECP transaction.
Formal signing of the USPP is
expected to occur in the coming weeks, and issue of the USPP notes
is expected to occur in Q2 2024, subject to the closing of the ECP
transaction and the satisfaction of customary
conditions.
Bridgepoint believes that the
transaction highlights US investors' confidence in the Group's
credit quality well as in its growth strategy over the longer
term.
ENQUIRIES
Bridgepoint
FGS Global (Public Relations Adviser
to Bridgepoint)
Charles O'Brien / +44 20 7251 3801 /
+44 7825 043 656
Anjali Unnikrishnan / +44 20 7251
3801 / +44 7826 534 233
bridgepoint@fgsglobal.com
Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472
Cautionary Statement
This announcement should not be
construed as an investment recommendation nor does it constitute an
offer to sell or the solicitation of any offer to buy interests in
any security. Offers may only be made at the time a qualified
offeree receives the related confidential information memorandum
for a specific investment describing the offering and executes a
related subscription agreement. Any interests in securities of
Bridgepoint or any of its subsidiaries shall not be offered or sold
in any jurisdiction in which such an offer, solicitation or sale
would be unlawful until the requirements of the laws of such
jurisdiction have been satisfied. Any investment decisions with
respect to any securities should be made solely based on the
information contained in the respective final offering
documentation.
Information Regarding Forward-Looking
Statements
The information contained in this
announcement may contain forward-looking statements that reflect
Bridgepoint's current views with respect to, among other things,
future financial and business performance events, strategies and
expectations. Bridgepoint generally identifies forward-looking
statements by terminology such as "outlook," "believe," "expect,"
"potential," "continue," "may," "will," "should," "seeks,"
"approximately," "predicts," "intends," "plans," "estimates,"
"anticipates" or the negative version of those words or other
comparable words. Any forward-looking statements contained in this
announcement are based upon historical performance and market
information, and on Bridgepoint's current plans, estimates and
expectations. The inclusion of this forward-looking information
should not be regarded as a representation by Bridgepoint or any
other person that the future plans, estimates or expectations
contemplated by Bridgepoint will be achieved. Such forward-looking
statements are subject to various risks and uncertainties, as well
as assumptions relating to Bridgepoint's operations, financial
results, financial condition, business prospects, growth strategy
and liquidity. If one or more of these or other risks or
uncertainties materialize, or if underlying assumptions prove to be
incorrect, Bridgepoint's actual results may vary materially from
those indicated in these statements. Any forward-looking
statements, views, and opinions contained in this announcement are
current as of the date of this announcement but are subject to
change. Except as required by applicable law, Bridgepoint does not
undertake any obligation to update or review any forward-looking
statement, views, and opinions, whether as a result of new
information, future developments or otherwise.